SIN3A

SIN3 transcription regulator family member A, the group of SIN3 histone deacetylase complex subunits|EMSY complex

Basic information

Region (hg38): 15:75369379-75455842

Links

ENSG00000169375NCBI:25942OMIM:607776HGNC:19353Uniprot:Q96ST3AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • autism, susceptibility to, 15 (Strong), mode of inheritance: AD
  • chromosome 15q24 deletion syndrome (Strong), mode of inheritance: AD
  • SIN3A-related intellectual disability syndrome due to a point mutation (Supportive), mode of inheritance: AD
  • congenital diaphragmatic hernia (Limited), mode of inheritance: AD
  • chromosome 15q24 deletion syndrome (Strong), mode of inheritance: AD
  • SIN3A-related intellectual disability syndrome (Definitive), mode of inheritance: AD
  • SIN3A-related intellectual disability syndrome (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Witteveen-Kolk syndromeADGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingCraniofacial; Musculoskeletal; Neurologic27399968

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SIN3A gene.

  • not provided (23 variants)
  • SIN3A-related intellectual disability syndrome due to a point mutation (13 variants)
  • Inborn genetic diseases (8 variants)
  • SIN3A-related intellectual disability syndrome (1 variants)
  • See cases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SIN3A gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
118
clinvar
8
clinvar
129
missense
6
clinvar
185
clinvar
11
clinvar
202
nonsense
17
clinvar
6
clinvar
1
clinvar
24
start loss
0
frameshift
22
clinvar
9
clinvar
1
clinvar
32
inframe indel
1
clinvar
3
clinvar
4
splice donor/acceptor (+/-2bp)
2
clinvar
6
clinvar
8
splice region
2
7
13
4
26
non coding
1
clinvar
3
clinvar
37
clinvar
10
clinvar
51
Total 42 28 196 166 18

Variants in SIN3A

This is a list of pathogenic ClinVar variants found in the SIN3A region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
15-75371996-C-T Uncertain significance (Jun 03, 2023)2764683
15-75372002-C-T Uncertain significance (Jul 01, 2022)1988667
15-75372007-T-C Uncertain significance (Nov 30, 2022)2900796
15-75372009-GACACGAT-G SIN3A-related intellectual disability syndrome due to a point mutation Likely pathogenic (Oct 04, 2022)1708246
15-75372042-G-C Likely benign (Oct 22, 2023)2789196
15-75372043-G-C Uncertain significance (Nov 14, 2023)3364322
15-75372063-G-A Likely benign (Dec 06, 2023)2159914
15-75372066-A-G Likely benign (Oct 14, 2022)1923053
15-75372068-A-G Uncertain significance (Sep 01, 2022)1711388
15-75372085-A-G Uncertain significance (Apr 24, 2022)2172970
15-75372099-G-A Likely benign (May 01, 2022)2645556
15-75372120-T-C Likely benign (Oct 03, 2023)2104179
15-75372125-T-C Inborn genetic diseases Uncertain significance (May 08, 2024)3318555
15-75372130-C-T Uncertain significance (Aug 22, 2022)2153463
15-75372131-G-A Conflicting classifications of pathogenicity (Jan 15, 2024)1424586
15-75372132-G-C Likely benign (Mar 06, 2018)709281
15-75372148-G-C SIN3A-related intellectual disability syndrome due to a point mutation Conflicting classifications of pathogenicity (Sep 20, 2024)2435950
15-75372158-C-T Uncertain significance (Dec 28, 2023)2185011
15-75372160-AC-A Uncertain significance (Jan 05, 2018)504080
15-75372161-C-T SIN3A-related intellectual disability syndrome due to a point mutation Uncertain significance (Jan 12, 2021)1299295
15-75372162-C-G Inborn genetic diseases Uncertain significance (Sep 29, 2023)3162316
15-75372165-G-A Benign (Jul 16, 2023)2175077
15-75372177-C-G Inborn genetic diseases Uncertain significance (Aug 26, 2022)2077616
15-75372181-T-C SIN3A-related intellectual disability syndrome due to a point mutation Uncertain significance (Mar 19, 2021)2435947
15-75372187-C-T SIN3A-related intellectual disability syndrome due to a point mutation Uncertain significance (Jul 29, 2021)1696625

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SIN3Aprotein_codingprotein_codingENST00000394947 2086464
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.001.04e-10125744031257470.0000119
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense4.393867170.5380.00004038373
Missense in Polyphen61239.210.255012972
Synonymous0.1932622660.9850.00001442446
Loss of Function7.50167.40.01480.00000379738

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00006150.0000615
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00001760.0000176
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Acts as a transcriptional repressor. Corepressor for REST. Interacts with MXI1 to repress MYC responsive genes and antagonize MYC oncogenic activities. Also interacts with MXD1-MAX heterodimers to repress transcription by tethering SIN3A to DNA. Acts cooperatively with OGT to repress transcription in parallel with histone deacetylation. Involved in he control of the circadian rhythms. Required for the transcriptional repression of circadian target genes, such as PER1, mediated by the large PER complex through histone deacetylation. Cooperates with FOXK1 to regulate cell cycle progression probably by repressing cell cycle inhibitor genes expression (By similarity). {ECO:0000250|UniProtKB:Q60520, ECO:0000269|PubMed:12150998}.;
Pathway
Huntington,s disease - Homo sapiens (human);Thyroid hormone signaling pathway - Homo sapiens (human);Transcriptional misregulation in cancer - Homo sapiens (human);Androgen receptor signaling pathway;Retinoblastoma (RB) in Cancer;MECP2 and Associated Rett Syndrome;TGF-beta Signaling Pathway;Hedgehog Signaling Pathway;NoRC negatively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;Epigenetic regulation of gene expression;Gene expression (Transcription);mets affect on macrophage differentiation;Generic Transcription Pathway;Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);Metabolism of lipids;Factors involved in megakaryocyte development and platelet production;RNA Polymerase II Transcription;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;Metabolism;AndrogenReceptor;Hemostasis;C-MYB transcription factor network;Transcriptional regulation by RUNX1;Regulation of Telomerase;Signaling events mediated by HDAC Class I;Hedgehog signaling events mediated by Gli proteins;Regulation of nuclear SMAD2/3 signaling (Consensus)

Recessive Scores

pRec
0.372

Intolerance Scores

loftool
rvis_EVS
-1.39
rvis_percentile_EVS
4.27

Haploinsufficiency Scores

pHI
0.925
hipred
Y
hipred_score
0.786
ghis
0.620

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
H
gene_indispensability_pred
E
gene_indispensability_score
1.00

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Sin3a
Phenotype
normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;in utero embryonic development;activation of innate immune response;positive regulation of defense response to virus by host;hematopoietic progenitor cell differentiation;DNA replication;protein deacetylation;aging;regulation of hormone levels;positive regulation of G2/M transition of mitotic cell cycle;histone deacetylation;regulation of lipid metabolic process;positive regulation of chromatin silencing;cellular protein localization;negative regulation of circadian rhythm;negative regulation of apoptotic process;regulation of transcription from RNA polymerase II promoter in response to oxidative stress;regulation of megakaryocyte differentiation;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;rhythmic process;response to methylglyoxal;cellular response to glucose stimulus;negative regulation of protein localization to nucleus;negative regulation of histone H3-K27 acetylation;cellular response to dopamine;negative regulation of transcription regulatory region DNA binding
Cellular component
kinetochore;chromatin;nucleus;nucleoplasm;transcription factor complex;nucleolus;Sin3 complex;transcriptional repressor complex
Molecular function
transcription regulatory region sequence-specific DNA binding;RNA polymerase II activating transcription factor binding;RNA polymerase II repressing transcription factor binding;chromatin binding;DNA-binding transcription factor activity;transcription corepressor activity;RNA binding;histone deacetylase activity;protein binding;protein deacetylase activity;protein-containing complex binding